BioCentury
ARTICLE | Company News

Compugen, Bayer deal

August 12, 2013 7:00 AM UTC

The companies partnered to research and develop antibody-based cancer immunotherapies against two undisclosed immune checkpoint regulators discovered by Compugen. Compugen will be responsible for anti...